Guidance for management of cancer surgery during the COVID-19 pandemic

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Summary

During the coronavirus disease 2019 (COVID-19) pandemic, delaying lifesaving cancer surgeries must be done with extreme caution and thoughtfulness. Modelling indicates that delays in high-risk cancer surgeries beyond 6 weeks could affect long-term outcomes for thousands of Canadians. Consequently, it is possible that postponing cancer surgery without consideration of its implications could cost more lives than can be saved by diverting all surgical resources to COVID-19. This article provides general guidance on supporting curative surgical treatment where appropriate and with available resources.

Related collections

Author and article information

Journal

Journal ID (nlm-ta): Can J Surg

Journal ID (iso-abbrev): Can J Surg

Journal ID (publisher-id): 0372715

Title: Canadian Journal of Surgery

Publisher: Joule Inc.

ISSN (Print): 0008-428X

ISSN (Electronic): 1488-2310

Publication date (Print): April 2020

Volume: 63

Issue: 2 Suppl 1

Pages: S2-S4

Affiliations

From the Canadian Partnership Against Cancer (Finley, Prashad, Camuso, Daly, Earle); the Canadian Network of Surgical Associations for Cancer Care (Aprikian, Ball, Bentley, Charest, Fata, Helyer, O’Connell, Moloo, Seely, Werier, Zhong); the Canadian Urological Association and the Division of Urology, Department of Surgery, McGill University, Montreal, Que. (Aprikian); the Canadian Hepato-Pancreatico-Biliary Association and the Department of Surgery, University of Calgary, Calgary, Alta. (Ball); the Society for Gynecologic Oncology of Canada and the Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, NS (Bentley); the Canadian Neurosurgical Society and the Department of Neurosurgery, Dalhousie University New Brunswick, Moncton, NB (Charest); the Canadian Association of General Surgeons and the Division of General Surgery, Department of Surgery, McGill University, Montreal, Que. (Fata); the Canadian Society of Surgical Oncology and the Department of General Surgery, Dalhousie University, Halifax, NS (Helyer); the Canadian Association of Head and Neck Surgical Oncology and the Division of Otolaryngology – Head and Neck Surgery, University of Alberta, Edmonton, Alta.(O’Connell); the Canadian Society of Colon and Rectal Surgeons and the Division of General Surgery, Department of Surgery, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Ont. (Moloo); the Canadian Association of Thoracic Surgeons and the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont. (Seely); the Canadian Orthopaedic Oncology Society and the Division of Orthopaedic Surgery, Department of Surgery, University of Ottawa, Ottawa, Ont. (Werier); the Canadian Society of Plastic Surgeons and the Department of Surgery, University of Toronto, Toronto, Ont. (Zhong); the Department of Surgery, McMaster University, Hamilton, Ont. (Finley); the Department of Gastrointestinal Oncology, Sunnybrook Health Sciences Centre, Toronto, Ont. (Earle); and the Canadian Journal of Surgery (Ball)

Author notes

Correspondence to: C. Finley, Cancer Control, Canadian Partnership Against Cancer, 145 King Street West, Toronto ON M5H 1J8, Christian.Finley@ 123456partnershipagainstcancer.ca

Article

Accession ID: PMC7828991 Pmcid ID: PMC7828991 Pmc-uid ID: 7828991 Publisher ID: 06300s2

DOI: 10.1503/cjs.005620

PMC ID: 7828991

PubMed ID: 32343118

SO-VID: 46f96a91-c4c5-4c49-8201-1d26de976368

History

Comments

Comment on this article

scite_

Cited by 36

See all cited by

- Version 1